Galmed Pharmaceuticals Ltd.

GLMD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,652$2,861$2,016$2,884
Short-Term Investments$10,679$9,781$11,769$31,931
Receivables$209$165$0$79
Inventory$0$0$114$0
Other Curr. Assets$584$432$668$1,160
Total Curr. Assets$16,124$13,239$14,724$36,054
Property Plant & Equip (Net)$0$125$337$551
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,119$3,265$1,500$0
Tax Assets$0$0$0$0
Other NC Assets$257$0$0$0
Total NC Assets$2,376$3,390$1,837$551
Other Assets$0$0$0$0
Total Assets$18,500$16,629$16,561$36,605
Liabilities
Payables$1,308$1,879$2,560$4,871
Short-Term Debt$0$41$171$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0-$171$0
Other Curr. Liab.$865$830$363$1,008
Total Curr. Liab.$2,173$2,750$3,094$5,879
LT Debt$0$0$44$229
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$44$229
Other Liabilities$0$0$0$0
Cap. Leases$0$41$215$229
Total Liabilities$2,173$2,750$3,138$6,108
Equity
Pref Stock$0$0$0$0
Common Stock$742$209$70$70
Retained Earnings-$200,469-$192,952-$186,040-$168,174
AOCI-$416-$454-$745-$171
Other Equity$216,470$207,076$200,138$198,772
Total Equity$16,327$13,879$13,423$30,497
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$18,500$16,629$16,561$36,605
Net Debt-$4,652-$2,820-$1,801-$2,655
Galmed Pharmaceuticals Ltd. (GLMD) Financial Statements & Key Stats | AlphaPilot